BioGaia AB (publ) BIOG-B.ST Stock
BioGaia AB (publ) Price Chart
BioGaia AB (publ) BIOG-B.ST Financial and Trading Overview
| BioGaia AB (publ) stock price | 123.7 SEK |
| Previous Close | 112.5 SEK |
| Open | 112.4 SEK |
| Bid | 111.9 SEK x 0 |
| Ask | 112.1 SEK x 0 |
| Day's Range | 110.8 - 112.4 SEK |
| 52 Week Range | 68.88 - 114.9 SEK |
| Volume | 9.71K SEK |
| Avg. Volume | 107.58K SEK |
| Market Cap | 11.18B SEK |
| Beta (5Y Monthly) | 0.693103 |
| PE Ratio (TTM) | 5.8608055 |
| EPS (TTM) | 3.67 SEK |
| Forward Dividend & Yield | 1.45 (1.33%) |
| Ex-Dividend Date | May 8, 2023 |
| 1y Target Est | 122.5 SEK |
BIOG-B.ST Valuation Measures
| Enterprise Value | 9.54B SEK |
| Trailing P/E | 5.8608055 |
| Forward P/E | 31.37255 |
| PEG Ratio (5 yr expected) | 2.12 |
| Price/Sales (ttm) | 9.424486 |
| Price/Book (mrq) | 5.4195294 |
| Enterprise Value/Revenue | 8.042 |
| Enterprise Value/EBITDA | 23.839 |
Trading Information
BioGaia AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.693103 |
| 52-Week Change | 19.17% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 114.9 SEK |
| 52 Week Low | 68.88 SEK |
| 50-Day Moving Average | 100.37 SEK |
| 200-Day Moving Average | 91.51 SEK |
BIOG-B.ST Share Statistics
| Avg. Volume (3 month) | 107.58K SEK |
| Avg. Daily Volume (10-Days) | 105.09K SEK |
| Shares Outstanding | 97.28M |
| Float | 80.84M |
| Short Ratio | N/A |
| % Held by Insiders | 3.59% |
| % Held by Institutions | 52.69% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.45 |
| Trailing Annual Dividend Yield | 1.28% |
| 5 Year Average Dividend Yield | 108.00% |
| Payout Ratio | 0.038399998 |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 34.86% |
| Operating Margin (ttm) | 32.47% |
| Gross Margin | 72.70% |
| EBITDA Margin | 33.73% |
Management Effectiveness
| Return on Assets (ttm) | 10.56% |
| Return on Equity (ttm) | 20.44% |
Income Statement
| Revenue (ttm) | 1.19B SEK |
| Revenue Per Share (ttm) | 11.74 SEK |
| Quarterly Revenue Growth (yoy) | 28.89% |
| Gross Profit (ttm) | 801.93M SEK |
| EBITDA | 400.07M SEK |
| Net Income Avi to Common (ttm) | 413.42M SEK |
| Diluted EPS (ttm) | 19.11 |
| Quarterly Earnings Growth (yoy) | 52.00% |
Balance Sheet
| Total Cash (mrq) | 1.58B SEK |
| Total Cash Per Share (mrq) | 15.65 SEK |
| Total Debt (mrq) | 0 SEK |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 10.321 |
| Book Value Per Share (mrq) | 20.666 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 324.31M SEK |
| Levered Free Cash Flow (ttm) | 217.33M SEK |
Profile of BioGaia AB (publ)
| Country | Sweden |
| State | N/A |
| City | Stockholm |
| Address | Kungsbroplan 3 |
| ZIP | 112 27 |
| Phone | 46 8 55 52 93 00 |
| Website | https://www.biogaia.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 211 |
BioGaia AB (publ), a healthcare company, develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; Helicobacter pylorithe gastric ulcer bacterium; low bone density; and diverticulitis, as well as baby and child gut, adult gut, immune, pregnancy, oral, and bone health. It offers its products under the BioGaia brand name. The company sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.
Q&A For BioGaia AB (publ) Stock
What is a current BIOG-B.ST stock price?
BioGaia AB (publ) BIOG-B.ST stock price today per share is 123.7 SEK.
How to purchase BioGaia AB (publ) stock?
You can buy BIOG-B.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioGaia AB (publ)?
The stock symbol or ticker of BioGaia AB (publ) is BIOG-B.ST.
Which industry does the BioGaia AB (publ) company belong to?
The BioGaia AB (publ) industry is Drug Manufacturers-Specialty & Generic.
How many shares does BioGaia AB (publ) have in circulation?
The max supply of BioGaia AB (publ) shares is 100.98M.
What is BioGaia AB (publ) Price to Earnings Ratio (PE Ratio)?
BioGaia AB (publ) PE Ratio is 33.70572000 now.
What was BioGaia AB (publ) earnings per share over the trailing 12 months (TTM)?
BioGaia AB (publ) EPS is 3.67 SEK over the trailing 12 months.
Which sector does the BioGaia AB (publ) company belong to?
The BioGaia AB (publ) sector is Healthcare.
BioGaia AB (publ) BIOG-B.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| OMX Stockholm Benchmark_PI OMXSBPI | 816.03 SEK 79.66 USD |
-1.25
|
— — | 813.94 SEK 79.45 USD | 828.06 SEK 80.83 USD | — - | — — |
| OMX Stockholm Benchmark_GI OMXSBGI | 1936.56 SEK 189.03 USD |
+0.24
|
— — | 1931.58 SEK 188.55 USD | 1965.09 SEK 191.82 USD | — - | — — |
| OMX Stockholm Benchmark Cap_GI OMXSBCAPGI | 2257.49 SEK 220.36 USD |
-1.25
|
— — | 2251.71 SEK 219.79 USD | 2290.86 SEK 223.62 USD | — - | — — |
| OMX_Nordic_Mid_Cap_ISK_GI OMXNMCISKGI | 665.81 ISK 4.9 USD |
-1.4
|
— — | 663.14 ISK 4.88 USD | 676.93 ISK 4.98 USD | — - | — — |
| OMX Stockholm Health Care PI SX20PI | 3553.48 SEK 346.86 USD |
+0.34
|
— — | 3544.63 SEK 346 USD | 3577.03 SEK 349.16 USD | — - | — — |
| OMX_Nordic_Mid_Cap_DKK_GI OMXNMCDKKGI | 473.77 DKK 69.46 USD |
-1.39
|
— — | 472.29 DKK 69.25 USD | 481.63 DKK 70.62 USD | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030PI | 5704.1 SEK 556.79 USD |
+0.01
|
— — | 5704.1 SEK 556.79 USD | 5704.1 SEK 556.79 USD | — - | — — |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
| OMX Stockholm_PI OMXSPI | 971.63 SEK 94.84 USD |
-1.25
|
— — | 969.28 SEK 94.61 USD | 985.71 SEK 96.22 USD | — - | — — |
| NASDAQ OMX Small Cap Sweden GI NOMXSCSEGI | 4383.32 SEK 427.87 USD |
-1.43
|
— — | 4372.27 SEK 426.79 USD | 4458.63 SEK 435.22 USD | — - | — — |
| OMX_Stockholm_Mid_Cap_GI OMXSMCGI | 879.99 SEK 85.9 USD |
-1.54
|
— — | 877.47 SEK 85.65 USD | 895.71 SEK 87.43 USD | — - | — — |
| OMX Stockholm All-Share Cap_GI OMXSCAPGI | 473.06 SEK 46.18 USD |
-1.24
|
— — | 471.92 SEK 46.07 USD | 479.91 SEK 46.85 USD | — - | — — |
| OMX Stockholm Benchmark_GI Exp OMXSBGIEXP | 1940.65 SEK 189.43 USD |
-1.38
|
— — | 1940.65 SEK 189.43 USD | 1964.23 SEK 191.73 USD | — - | — — |
| OMX Stockholm Benchmark Cap_PI OMXSBCAPPI | 935.79 SEK 91.34 USD |
-1.25
|
— — | 933.39 SEK 91.11 USD | 949.62 SEK 92.69 USD | — - | — — |
| OMX_Nordic_Mid_Cap_SEK_GI OMXNMCSEKGI | 575.33 SEK 56.16 USD |
-1.29
|
— — | 574.09 SEK 56.04 USD | 583.89 SEK 56.99 USD | — - | — — |
| OMX Stockholm Health Care PI SX4000PI | 2712.52 SEK 264.78 USD |
<0.01
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Mid_Cap_EUR_GI OMXNMCEURGI | 473.57 EUR 517.68 USD |
-1.4
|
— — | 472.1 EUR 516.07 USD | 481.48 EUR 526.32 USD | — - | — — |
| OMX Stockholm Health Care GI SX20GI | 4578.33 SEK 446.9 USD |
-0.28
|
— — | 4566.92 SEK 445.79 USD | 4608.67 SEK 449.86 USD | — - | — — |
| OMX Affarsvarldens Generalindex OMXAFGX | 947.67 SEK 92.5 USD |
-1.25
|
— — | 945.39 SEK 92.28 USD | 961.43 SEK 93.85 USD | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030GI | 7742.42 SEK 755.76 USD |
+0.01
|
— — | 7742.42 SEK 755.76 USD | 7742.42 SEK 755.76 USD | — - | — — |
- {{ link.label }} {{link}}